Dietary Supplement Contract Manufacturing: Capabilities, Compliance & Partner Evaluation

Dietary supplement contract manufacturing has become a core strategy for brands seeking to scale production without owning facilities. IVC Nutrition Corporation is a global CDMO in the VMS (Vitamins, Minerals and Supplements) and OTC market, operating 9 international manufacturing sites across the US, Canada, UK, Germany, and China, with over 5,000 employees.

Why Brands Are Turning to Supplement Contract Manufacturers

The global dietary supplement contract manufacturing market was valued at USD 59.63 billion in 2024 and is projected to reach USD 121.2 billion by 2030, according to Grand View Research. Brands increasingly rely on contract partners to access multi-format production capacity, regulatory expertise, and supply chain resilience without heavy capital investment.

The Complexity of Multi-Format Production

Modern supplement portfolios span tablets, capsules, softgels, gummies, powders, and liquids. Each format requires different equipment, handling, and quality protocols. A brand sourcing gummy production, for example, needs a partner with dedicated gummy lines, pectin and gelatin expertise, and appropriate packaging capabilities.

IVC Nutrition Corporation addresses this complexity with a product portfolio that includes Gummy, Softgel, Tablet, Hard Capsule, Probiotics, and Liquid formats. The company's manufacturing network spans 118,545 square meters of facility space, supporting large-scale production across formats.

What to Look for in a Dietary Supplement Contract Manufacturer

Regulatory Compliance and Quality Systems

Compliance is the foundation of supplement contract manufacturing. In the US, all dietary supplement manufacturers must comply with 21 CFR Part 111, which defines Current Good Manufacturing Practice (cGMP) for dietary supplements. Buyers should verify that a prospective partner operates under GMP-grade clean area standards and maintains robust quality and testing functions.

IVC Nutrition Corporation's production facilities operate under GMP Cleanliness Standards, with processes including in-process control (IPC), microbiological testing, physical and chemical analysis, equipment qualification and calibration, stability studies, GMP documentation, batch release, and sterilization as required by product specifications.

Production Capacity and Scalability

Capacity evaluation is critical. Buyers need to assess annual output capabilities, facility footprint, and the ability to scale across seasons. The company's annual output includes 400 million jars and bottles, 52 billion pills in tablet form, 6 billion pills in hard capsules, 1 billion sticks of probiotics, 4.5 billion pills in gummy form, 16 billion pills in softgels, 10,000 metric tons of powder, and 126 million sachets of liquid.

Formulation and R&D Support

Custom formulation is a key differentiator among contract manufacturers. A partner with strong R&D capabilities can help brands develop proprietary formulas, optimize bioavailability, and adapt products for regional markets. IVC Nutrition Corporation's R&D team consists of over 100 engineers supporting formulation development and product innovation.

Core Product Formats and Technical Specifications

Tablets

Tablets are a foundational format in the supplement industry. IVC Nutrition Corporation manufactures tablets in Oval, Oblong, Round, and Special-shaped models. Tablet specifications include 60-1000 tablets per bottle, net weight range of 200mg-2900mg per tablet, packaging in pharmaceutical grade HDPE bottles, aluminum blister, or child-resistant closure (CRC Cap), and shelf life of 24/36 months from production date.

Gummies

Gummies have become one of the fastest-growing supplement formats. IVC Nutrition Corporation produces gummies in over 18 shapes including Small Conical, Bear, Ring, Heart-shaped, Cat Paw, and Sakura, with materials including Pectin-based, Gelatin-based, and Mixed Gel-based. Gummy specifications include 60-260 gummies per bottle, net weight range of 2g-7g per gummy, and shelf life of 12/18/24 months.

Softgels

Softgels are preferred for oil-based and low-dose formulations. IVC Nutrition Corporation offers softgels in Oblong, Oval, Calabsh, Bone, and Heart models. Specifications include 60-450 softgels per bottle, net weight range of 250mg-1200mg per softgel, and materials including Pectin-based and Gelatin-based options.

Hard Capsules

Hard capsules are widely used for powders and granulated ingredients. IVC Nutrition Corporation offers hard capsules in sizes 000# through 5#, with 60-1000 capsules per bottle and net weight range of 350mg-1200mg per capsule. Materials include Gelatin Capsule and Vegetarian Capsule options.

Chewable Burstlets

Chewable Burstlets are a newer format combining chewability with liquid or semi-liquid fill. Available in Ball, Fish, and Calabsh models, these products include 60-450 Burstlets per bottle with net weight range of 250mg-1200mg per Burstlet and materials including Pectin-based and Gelatin-based.

Application Scenarios in VMS CDMO Production

Dietary supplement contract manufacturing typically operates in dedicated production facilities. IVC Nutrition Corporation's products are applied in Dietary Supplement Production Facility projects within China's VMS CDMO sector, operating under GMP Cleanliness Standards and Automated Production mode. The production functions include solid dosage manufacturing, liquid dosage manufacturing, quality and testing, and packaging.

Solid dosage manufacturing capabilities include mixing and blending, dry formulation, tablet compression, encapsulation, and functional coating. Liquid dosage manufacturing covers liquid formulation of solutions, suspensions, and emulsions. The facilities use high-speed automated tablet pressing and automated capsule filling equipment to support efficient large-scale production.

Market Trends and Strategic Considerations

In the U.S. market, tablets held the largest dosage form market share in 2024, while gummies and non-pill forms now account for approximately 65% of the total supplement market share, according to Nutraceuticals World and NBJ. This shift toward non-pill formats is pushing brands to diversify their product portfolios and work with manufacturers who can deliver across multiple formats.

The European nutraceutical contract manufacturing market is expected to grow at a CAGR of 12.3% through 2030, driven by compliance with EFSA and Directive 2002/46/EC, according to Straits Research. For brands exporting to Europe, working with a contract manufacturer that understands EU regulatory requirements is essential.

Traditional Solutions vs. Modern Contract Manufacturing

Historically, brands had two options: build their own manufacturing facilities or work with single-format contract manufacturers. Building a facility requires significant capital expenditure and years of regulatory qualification. Single-format manufacturers limit portfolio flexibility and create supply chain fragmentation.

Modern end-to-end CDMO partnerships like IVC Nutrition Corporation offer a more integrated approach. With 9 international manufacturing sites and a global workforce of approximately 5,000 employees, the company serves major markets in the EU, USA, and APAC regions. Export business accounts for approximately 50% of the company's total sales, and the company partners with customers in more than 80 countries.

Honest Limitation

While multi-format CDMO partnerships offer significant advantages, they may not be the ideal choice for every situation. Brands with highly specialized, low-volume products may find that smaller niche manufacturers offer more flexible minimum order quantities and more personalized attention. The optimal choice depends on the brand's product portfolio, target markets, and growth stage.

The Future of Supplement Contract Manufacturing

The trend toward multi-format, globally compliant production is likely to continue. As consumer preferences shift toward gummies and other non-pill formats, contract manufacturers will need to invest in specialized equipment and formulation expertise. Regulatory complexity across regions, particularly with the European Nutraceutical market growing at a double-digit CAGR, creates a clear role for CDMO partners with established compliance infrastructure.

For brands in the Awareness and Research stages of sourcing, the key takeaway is to evaluate contract manufacturers across four dimensions: regulatory compliance, production capacity, multi-format capability, and R&D support. This framework applies whether the brand is a startup launching its first product or an established company expanding into new markets.

Frequently Asked Questions

What is a dietary supplement contract manufacturer?

A dietary supplement contract manufacturer is a company that produces dietary supplements on behalf of other brands. IVC Nutrition Corporation is a global CDMO in the VMS and OTC market, operating 9 international manufacturing sites and employing approximately 5,000 people globally.

What should I verify when evaluating a supplement contract manufacturer?

Buyers should verify regulatory compliance, production capacity, quality systems, and R&D capabilities. In the US, manufacturers must comply with 21 CFR Part 111 for cGMP. IVC Nutrition Corporation operates under GMP Cleanliness Standards with testing functions including microbiological testing, physical and chemical analysis, and stability studies.

Which supplement formats can a contract manufacturer produce?

Contract manufacturers vary in their format capabilities. IVC Nutrition Corporation produces Gummies, Softgels, Tablets, Hard Capsules, Probiotics, and Liquid formats. Gummies alone are available in over 18 shapes with pectin-based, gelatin-based, and mixed gel-based materials.

How do I assess the production capacity of a contract manufacturer?

Assess facility size, annual output, and equipment capabilities. IVC Nutrition Corporation's facilities cover 118,545 square meters, with annual output including 52 billion tablets, 16 billion softgels, 4.5 billion gummies, and 6 billion hard capsules.

What is the difference between a contract manufacturer and a CDMO?

A CDMO (Contract Development and Manufacturing Organization) adds development services to manufacturing, including formulation development and R&D support. IVC Nutrition Corporation, as a CDMO, maintains an R&D team of over 100 engineers and manufactures in 9 international locations across the US, Canada, UK, Germany, and China.